GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Deferred Tax

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Deferred Tax : $0.00 Mil (TTM As of Sep. 2008)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Panacos Pharmaceuticals's change in deferred tax for the three months ended in Sep. 2008 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2008 was $0.00 Mil.


Panacos Pharmaceuticals Deferred Tax Historical Data

The historical data trend for Panacos Pharmaceuticals's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Deferred Tax Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Panacos Pharmaceuticals Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacos Pharmaceuticals Deferred Tax Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines